Eltrombopag for Inherited Thrombocytopenias

NCT02422394 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Inherited Platelet Disorder

Interventions

DRUG: Eltrombopag

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia